Simone Brixius‐Anderko
Papers
1
Total Citations
35
H-Index
1
About
Simone Brixius‐Anderko is a leading researcher in the field of biocatalysis and cytochrome P450 engineering, with a particular focus on the human mitochondrial CYP11B1 enzyme. Her major contribution lies in the development of a recombinant E. coli biocatalyst capable of the selective, one-step 11β-hydroxylation of 11-deoxycortisol to produce cortisol—a critical stress hormone and widely used anti-inflammatory therapeutic. This work, published in 2015 and cited 35 times, represents a significant advance in the preparative-scale synthesis of cortisol, offering a more efficient and selective alternative to traditional chemical methods. By optimizing the biocatalyst for scalability, Brixius‐Anderko has paved the way for greener, more sustainable production of pharmaceutically relevant steroids. Her research bridges fundamental enzymology and applied biotechnology, demonstrating the power of engineered microbial systems for complex, regioselective hydroxylations. For students and researchers, her work exemplifies how understanding enzyme mechanisms can lead to practical, industrial-scale solutions in drug manufacturing and synthetic biology.
Research Focus
Key Achievements
Top Papers
- 1